It could be shown that elevated serum levels of syndecan-1 (SDC1) are linked to a heightened risk of developing ARDS in patients with septic shock [14] and non-pulmonary sepsis [28]. This evidence concerns the gene SDC1 and acute respiratory distress syndrome.